| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |